Moderna and IBM have announced a partnership to use generative artificial intelligence and quantum computing to advance messenger RNA (mRNA) technology. This technology is at the core of Moderna's Covid-19 vaccine, which has been highly effective in protecting against the virus. IBM's quantum computing systems could help Moderna accelerate the discovery and creation of new mRNA vaccines and therapies, and IBM will provide experts to help Moderna scientists explore the use of quantum technologies in this area. Moderna will also have access to IBM's generative AI model to design a new class of vaccines and therapies.

The agreement comes as Moderna looks to harness its mRNA technology to target other diseases beyond Covid. IBM is also investing in AI with new partnerships, including a deal with NASA to build AI foundation models to advance climate science.